CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

Scope & Guideline

Exploring the Depths of Eukaryotic Gene Regulation

Introduction

Welcome to the CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1045-4403
PublisherBEGELL HOUSE INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1990 to 2024
AbbreviationCRIT REV EUKAR GENE / Crit. Rev. Eukaryot. Gene Expr.
Frequency3 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address50 NORTH ST, DANBURY, CT 06810

Aims and Scopes

The journal 'Critical Reviews in Eukaryotic Gene Expression' is dedicated to advancing the understanding of gene expression mechanisms and their implications in various biological processes and diseases, particularly cancer. It emphasizes the integration of molecular biology, genetics, and bioinformatics to elucidate the complexities of gene regulation and expression.
  1. Gene Regulation Mechanisms:
    The journal focuses on the diverse mechanisms that regulate gene expression, including epigenetic modifications, transcriptional control, and post-transcriptional modifications like RNA splicing and degradation.
  2. Cancer Biology and Therapeutics:
    A significant portion of the published research addresses the role of gene expression in cancer biology, exploring how alterations in gene regulation contribute to tumorigenesis, metastasis, and therapeutic resistance.
  3. Molecular Pathways and Signaling:
    Research articles frequently investigate specific signaling pathways and their role in modulating gene expression, particularly in the context of various diseases, including cancer and neurodegenerative disorders.
  4. Comparative Genomics and Transcriptomics:
    The journal also highlights studies that employ comparative genomics and transcriptomic analyses to understand gene expression patterns across different species or cancer types, providing insights into evolutionary biology and disease mechanisms.
  5. Stem Cells and Regenerative Medicine:
    Another area of focus is the role of gene expression in stem cell biology and regenerative medicine, exploring how gene regulation affects stem cell differentiation and therapeutic applications.
The journal has evolved over time, with certain themes gaining traction in recent publications. This section highlights the emerging trends that reflect the current research landscape in gene expression and its applications.
  1. Cancer Immunotherapy and Gene Expression:
    Recent publications show a growing interest in the relationship between gene expression profiles and cancer immunotherapy outcomes, highlighting the importance of understanding immune evasion mechanisms and potential biomarkers for therapy response.
  2. Single-Cell Transcriptomics:
    There is an increasing emphasis on single-cell transcriptomic studies, which allow for a more nuanced understanding of gene expression heterogeneity within tumors and other tissues, providing insights into cellular dynamics and disease progression.
  3. Multi-Omics Approaches:
    The integration of various omics data (genomics, transcriptomics, proteomics) is becoming a prominent theme, reflecting a trend towards comprehensive analyses that provide a holistic view of gene regulation and its impact on health and disease.
  4. Role of Epigenetics in Disease:
    The exploration of epigenetic modifications and their influence on gene expression is gaining more attention, particularly in the context of cancer and chronic diseases, indicating a shift towards understanding the complex regulatory networks governing gene activity.
  5. Therapeutic Applications of Gene Editing:
    Emerging research is increasingly focusing on gene editing technologies, such as CRISPR, and their potential therapeutic applications in treating genetic disorders and cancers, reflecting a significant trend towards translational research.

Declining or Waning

While the journal has consistently focused on gene expression and its biological implications, certain topics have shown signs of declining emphasis in recent publications. This section outlines the themes that appear to be waning in prominence.
  1. Non-Coding RNA Studies:
    Although non-coding RNAs, including microRNAs and long non-coding RNAs, were once a major focus, the frequency of papers specifically examining their roles in gene regulation has decreased, suggesting a shift towards more mechanistic and pathway-oriented studies.
  2. Basic Research on Gene Expression Techniques:
    There appears to be a declining interest in publishing foundational research on traditional gene expression techniques and methodologies, as the field moves towards more integrative and systems biology approaches.
  3. Environmental Influences on Gene Expression:
    Research exploring the impact of environmental factors on gene expression, while still relevant, has seen fewer dedicated studies, indicating a possible shift towards more direct investigations of genetic and epigenetic mechanisms.

Similar Journals

DEVELOPMENT GROWTH & DIFFERENTIATION

Unlocking the Secrets of Growth and Differentiation
Publisher: WILEYISSN: 0012-1592Frequency: 9 issues/year

DEVELOPMENT GROWTH & DIFFERENTIATION, published by Wiley, stands as a vital journal in the realms of Cell Biology, Developmental Biology, and Medicine. With an ISSN of 0012-1592 and E-ISSN of 1440-169X, this esteemed journal has been a key player in the scientific community since its inception in 1969, continuing to contribute significantly to the understanding of developmental processes and mechanisms underlying growth and differentiation. Ranked Q3 in Cell Biology and Developmental Biology, and Q2 in miscellaneous aspects of Medicine as of 2023, the journal provides a platform for high-quality research articles, reviews, and critical insights that foster academic discourse in these vital fields. Although currently not available as open access, the journal ensures the availability of essential research to its global readership, facilitating collaboration and innovation. Researchers, professionals, and students alike will find DEVELOPMENT GROWTH & DIFFERENTIATION to be an invaluable resource for advancing knowledge and driving forward the scientific inquiry into the intricacies of biological development.

Molecular Cell

Connecting Molecular Genetics with Cellular Functionality.
Publisher: CELL PRESSISSN: 1097-2765Frequency: 24 issues/year

Molecular Cell, published by Cell Press, is a leading journal in the fields of cell biology and molecular biology. Established in 1997, this prestigious journal boasts a significant impact within the scientific community, evidenced by its impressive 2023 Scopus rankings, placing it in the top 2% of its field (Rank #10/410 in Molecular Biology, Rank #12/285 in Cell Biology). With a focus on cutting-edge research that bridges the gap between molecular genetics and cellular function, Molecular Cell serves as an essential platform for the dissemination of vital findings and innovative methodologies. Although it follows a traditional publishing model without Open Access options, its rigorous peer-review process and high standards ensure that articles published within these pages are of the utmost quality, making it an invaluable resource for researchers, professionals, and students alike seeking to stay at the forefront of scientific discovery. The journal's address is 50 Hampshire St, Floor 5, Cambridge, MA 02139, United States, reinforcing its commitment to fostering scientific excellence and collaboration.

GENES TO CELLS

Bridging Research and Discovery in Molecular Biology
Publisher: WILEYISSN: 1356-9597Frequency: 12 issues/year

GENES TO CELLS is a distinguished peer-reviewed journal published by Wiley, offering valuable insights into the intricate world of cell biology and genetics. With an ISSN of 1356-9597 and an E-ISSN of 1365-2443, this journal has been contributing to the academic community since its inception in 1996 and will continue its publishing journey until 2024. Recognized with a category quartile ranking of Q3 in both Cell Biology and Genetics, and Q2 in Medicine (Miscellaneous) as of 2023, it serves as an important platform for disseminating innovative research and reviews in molecular biology and related fields. Although it does not currently offer open access, the journal caters to a diverse readership by providing comprehensive studies that are essential for professionals, researchers, and students aiming to deepen their understanding of genetic mechanisms and cellular functions. Situated in the United Kingdom, GENES TO CELLS continues to play a pivotal role in shaping the future of biological research.

RNA Biology

Elevating RNA Studies to New Heights
Publisher: TAYLOR & FRANCIS INCISSN: 1547-6286Frequency: 12 issues/year

RNA Biology is a premier journal published by Taylor & Francis Inc, focusing on the intricate and evolving field of RNA research. With an ISSN of 1547-6286 and E-ISSN of 1555-8584, this journal has established itself as an essential resource for professionals, researchers, and students engaged in both molecular and cell biology. Recognized in the 2023 quartile rankings, RNA Biology holds a distinguished Q1 category in Molecular Biology and a Q2 category in Cell Biology, indicative of its significant impact and reputation within the scientific community. The journal emphasizes the importance of RNA in various biological processes, highlighting both fundamental and applied aspects, which is crucial for advancing our understanding of gene expression and regulation. With a strong Scopus ranking, including Rank #105/410 in Molecular Biology and Rank #83/285 in Cell Biology, RNA Biology is not just a publication but a vital platform for sharing groundbreaking findings and insights into RNA research. With a convergence that spans from 2004 to 2024, the journal promises to continue its legacy of excellence in disseminating important discoveries in RNA science, contributing richly to ongoing scientific dialogue and innovation.

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Synthesis of Cutting-edge Biochemical Discoveries
Publisher: TAYLOR & FRANCIS LTDISSN: 1040-9238Frequency: 6 issues/year

Welcome to Critical Reviews in Biochemistry and Molecular Biology, a premier academic journal published by Taylor & Francis Ltd, dedicated to advancing the fields of biochemistry and molecular biology. With an impressive impact factor and a Q1 ranking in both Biochemistry and Molecular Biology for 2023, this journal serves as a vital resource for researchers, professionals, and students eager to engage with cutting-edge reviews and analyses that synthesize the latest developments in these dynamic areas of study. Since its inception in 1972, the journal has maintained a commitment to high-quality scholarship, providing a platform for critical discussions that accelerate the discovery and understanding of biochemical processes and molecular interactions. Although not open access, its robust editorial peer-review process ensures that published articles meet the highest standards of scientific rigor, making it a trusted source for the scientific community. As we continue to converge toward 2024, we invite you to explore the extensive array of topics and findings that have shaped contemporary biochemistry and molecular biology.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Connecting researchers with breakthrough insights.
Publisher: ELSEVIERISSN: 0167-4889Frequency: 12 issues/year

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH is a premier journal published by Elsevier, dedicated to advancing the fields of cell biology and molecular biology. Established in 1982, this influential journal has been at the forefront of scientific research and innovation, currently holding esteemed positions with a Q2 ranking in Cell Biology and a Q1 ranking in Molecular Biology for 2023, reflecting its commitment to high-quality scholarship. With an impressive impact factor, it ranks in the 82nd and 78th percentiles for Molecular Biology and Cell Biology, respectively, amongst its peers. Researchers, professionals, and students will find this journal to be an invaluable resource for exploring the latest discoveries and methodologies in the molecular mechanisms underlying cellular functions. Although it is not an open-access journal, the insights offered in its pages contribute significantly to the scientific community's understanding of cellular and molecular processes, ensuring it remains a vital platform for disseminating cutting-edge research.

MOLECULAR GENETICS AND GENOMICS

Empowering Research Through Open Access Knowledge
Publisher: SPRINGER HEIDELBERGISSN: 1617-4615Frequency: 6 issues/year

MOLECULAR GENETICS AND GENOMICS is a distinguished journal published by SPRINGER HEIDELBERG that serves as a pivotal platform for the communication of cutting-edge research and developments in the fields of genetics, molecular biology, and medicine. With an ISSN of 1617-4615 and an E-ISSN of 1617-4623, this journal has established itself since its inception in 1994 as a significant resource for researchers aiming to explore the complexities of genetic interactions and their implications in various biological systems. The journal is indexed in Scopus, with respectable rankings in the Genetics, Molecular Biology, and Biochemistry categories, showcasing its position within the academic community. It is categorized in the 2023 rankings as Q3 in Genetics, Q2 in Medicine (miscellaneous), and Q3 in Molecular Biology, indicating its relevance and quality in the scientific discourse. The journal also promotes open access, ensuring that researchers and professionals can easily share and advance knowledge in the rapidly evolving disciplines of molecular genetics and genomics. As the journal continues to bridge the gap between experimental and theoretical research, it presents a vital space for innovation, fostering collaborations and scholarly exchange among its readership.

DNA AND CELL BIOLOGY

Exploring the Frontiers of Molecular Discovery
Publisher: MARY ANN LIEBERT, INCISSN: 1044-5498Frequency: 12 issues/year

DNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.

GENE

Empowering the Future of Genetics Research
Publisher: ELSEVIERISSN: 0378-1119Frequency: 48 issues/year

GENE, an esteemed journal published by Elsevier, serves as a vital resource for researchers and professionals in the fields of genetics and medicine. With an ISSN of 0378-1119 and an E-ISSN of 1879-0038, this scholarly journal has been at the forefront of genetic research since its inception in 1976 and is set to continue until 2025. Situated in the Netherlands, GENE is recognized for its significant contributions, reflected in its Q2 ranking in both Genetics and Miscellaneous Medicine categories for 2023. This positioning within the Scopus rankings demonstrates its impact and relevance in a competitive field, where it holds the rank of #129 out of 347 in Genetics, placing it within the 62nd percentile. Although it does not offer open access options, GENE provides invaluable insight into contemporary genetic research, thereby fostering academic discussions and advancements. Researchers, professionals, and students alike will find GENE an essential platform for disseminating knowledge and exploring innovative developments in genetics and associated sciences.

MOLECULAR AND CELLULAR BIOLOGY

Bridging Knowledge Gaps in Molecular Biology
Publisher: TAYLOR & FRANCIS INCISSN: 0270-7306Frequency: 24 issues/year

MOLECULAR AND CELLULAR BIOLOGY, published by TAYLOR & FRANCIS INC, stands as a preeminent platform for researchers, professionals, and students engaged in the dynamic field of molecular and cellular biology. Established in 1981 and ongoing into 2024, the journal features cutting-edge research that spans across vital sub-disciplines, garnering a strong impact in its contributions to the scientific community. With an impressive Q2 ranking in Cell Biology and Q1 ranking in Molecular Biology for 2023, it consistently publishes high-quality articles that reflect the latest advancements and discoveries within the field. The journal is particularly well-regarded for its rigorous peer-review process and commitment to scientific excellence, making it an invaluable resource for those seeking to deepen their understanding of molecular mechanisms and cellular processes. Although not open access, the journal offers diverse access options for researchers to reach the latest findings. By maintaining a strong focus on biochemistry, genetics, and molecular biology, MOLECULAR AND CELLULAR BIOLOGY remains essential reading for anyone looking to contribute to or stay informed about significant developments within this pivotal area of study.